An Investigation into the Potential of Targeting Escherichia coli rne mRNA with Locked Nucleic Acid (LNA) Gapmers as an Antibacterial Strategy (2021)

First Author: Goddard L
Attributed to:  sRNA-based therapeutics for disease caused by A. pleuropneumoniae funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/molecules26113414

PubMed Identifier: 34200016

Publication URI: http://europepmc.org/abstract/MED/34200016

Type: Journal Article/Review

Parent Publication: Molecules

Issue: 11

ISSN: 1420-3049